Monopar Therapeutics Inc
F:1IY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Monopar Therapeutics Inc
F:1IY
|
US |
|
M
|
Mitsubishi Estate Co Ltd
DUS:MES
|
JP |
|
S
|
Synopsys Inc
F:SYP
|
US |
|
SoftBank Group Corp
TSE:9984
|
JP |
|
Northisle Copper and Gold Inc
F:0N4
|
CA |
|
T
|
Telefonaktiebolaget LM Ericsson
XMUN:ERCB
|
SE |
|
N
|
NOW Inc
F:11N
|
US |
|
I
|
Imperial Oil Ltd
AMEX:IMO
|
CA |
|
T
|
Tessenderlo Group NV
SWB:TEZ
|
BE |
|
T
|
Telefonaktiebolaget LM Ericsson
SWB:ERCB
|
SE |
|
D
|
Dalipal Holdings Ltd
HKEX:1921
|
CN |
|
Impala Platinum Holdings Ltd
F:IPHB
|
ZA |
|
Soitec SA
F:SOH1
|
FR |
|
P
|
Ping An Insurance Group Co of China Ltd
XMUN:PZX
|
CN |
Bankruptcy Probability
Monopar Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Monopar Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
425.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Monopar Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Monopar Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
